Twin Health Valuation, Funding & Investors
Twin Health is valued at $1.4B as of September 2026.
Last Twin Health valuation
$1.4B
Undisclosed stage · Sep 2026
Last Twin Health funding round
$59M
Undisclosed stage · Sep 2026
Cumulative funding Twin Health raised
$409M
across 7 funding rounds
Key investors in Twin Health
ICONIQ Capital
Sequoia Capital
Peak XV Partners
Temasek
Sofina
Corner Ventures
About Twin Health
Twin Health is a Mountain View, California-headquartered digital health company offering an AI-driven Whole Body Digital Twin platform for metabolic disorders. The system uses wearable sensors to monitor glucose, activity, and sleep, generating personalized nutrition and lifestyle plans. Clinically validated to reverse type 2 diabetes, Twin Health operates clinics in the US and India.
Founded
2018
HQ
San Francisco, CAWebsite
Status
Privately held
Customer focus
B2C
Revenue model
Subscription
Valuation
$1.4B (Sep 2026)
Twin Health Valuation
Twin Health is currently valued at $1.4B, based on its undisclosed-stage round in September 2026.
Twin Health's valuation has grown 20x from $71M at its Series A in June 2020 to $1.4B in September 2026, across 5 priced rounds.
Twin Health valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Sep 2026 | Undisclosed stage | $1.4B |
| Aug 2025 | Series E | $950M |
| May 2025 | Undisclosed stage | $950M |
| Oct 2021 | Series C | $740M |
| Jun 2020 | Series A | $71M |
Twin Health Funding History
Twin Health has raised a total of $409M across 7 funding rounds.
Twin Health's first fundraising round was a $18M Series A in June 2020. The most recent completed round was a $59M undisclosed-stage round in September 2026.
Twin Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Sep 2026 | Undisclosed stage | - | $59M | $1.4B | Twin Health completed a Series F equity financing round on June 29, 2026, raising approximately $61.51 million from undisclosed investors at a post-money valuation of about $1.4 billion. The round was structured as preferred stock at a price of roughly $19.86 per share, with standard 1.0x non-participating liquidation preference and no stated dividend, reflecting a late-stage growth financing to support continued scaling of the business. The Series F round provided Twin Health with additional growth capital to expand deployment of its precision metabolic care platform with health plans and employer clients, accelerating product development and commercial expansion. It followed prior significant rounds, including a $50 million growth financing and a $53 million Series E round in 2025–2026, and positioned the company with a larger capital base to invest in clinical evidence, payer relationships, and operational scale as it deepens penetration in digital metabolic care. Twin Health is a health technology company focused on whole-body metabolic "digital twin" care, using AI-driven models of individual patients’ metabolism to guide personalized interventions for conditions such as type 2 diabetes and obesity. The company operates in the healthcare and remote patient monitoring space, working primarily with health plans and employers to deliver its platform to covered populations, and has raised several hundred million dollars across multiple venture rounds to support its clinical research, technology development, and commercial rollout. |
| Aug 2025 | Series E | Maj Invest Equity (lead); Temasek; ICONIQ Capital | $53M | $950M | Twin Health is a Silicon Valley-based metabolic health startup founded in 2018 by Jahangir Mohammed, utilizing AI-driven digital twin technology to create personalized real-time models of patients' metabolisms from thousands of data points including biomarkers, behaviors, and preferences. The platform provides continuous 24/7 guidance, daily personalized recommendations, and human coaching to address root causes of metabolic diseases like diabetes and obesity, enabling outcomes such as A1C reduction, weight loss, and medication elimination without reliance on high-cost drugs. On August 21, 2025, coinciding with publication of a Cleveland Clinic-led randomized trial in NEJM Catalyst showing 71% of participants lowered A1C and reduced medications, Twin Health raised $53 million in a Series E round led by Maj Invest Equity, with participation from existing investors ICONIQ Growth and Temasek Holdings. The funding brings the company's post-money valuation to more than $950 million, supporting accelerated commercial scaling among employers, health plans, and Fortune 500 clients in sectors like retail, healthcare, financial services, technology, and manufacturing, including partners such as Benjamin Moore, HCSC, Heritage Group Health Program, Invitation Homes, Bayview, and Medline. Twin Health operates on a performance-based pricing model where employers and health plans pay only upon achievement of specific clinical milestones, minimizing risk and aligning incentives with outcomes. The company reports strong traction with over 90% member retention, under 1% voluntary churn, and high conversion rates, positioning it at an inflection point for broader adoption amid demand for medication-free alternatives to GLP-1 strategies. Investors highlighted Twin Health's technological and commercial milestones, with Maj Invest partner Jannick Mortensen noting readiness for scaling across more employers and patients, and CEO Jeppe Christianson describing it as a paradigm shift in precise, scalable diabetes and obesity care. The approach differentiates from traditional solutions by focusing on precision medicine over population averages, combining AI with human support for sustainable, engaging health management. |
| May 2025 | Undisclosed stage | - | $49M | $950M | Twin Health is a Silicon Valley-based startup founded in 2018 by Jahangir Mohammed, specializing in AI-driven digital twin technology for metabolic health management, particularly type 2 diabetes reversal and weight loss without high-cost medications. The platform creates a personalized metabolic model to deliver precision treatments, demonstrated in a Cleveland Clinic-led randomized trial published in NEJM Catalyst, where 71% of participants lowered A1C levels and reduced medication use. It operates on a performance-based pricing model for employers and health plans, charging only upon achieving outcomes like A1C reduction or weight loss, with strong metrics including 90%+ retention and under 1% voluntary churn. The company raised $53 million in a Series E funding round around May 23, 2025, led by Maj Invest with participation from existing investors like Iconiq and Temasek, bringing total funding to approximately $301-304 million across multiple rounds. This round valued Twin Health at close to or over $950 million post-money, positioning it near unicorn status. Prior rounds included a $50 million Series D in December 2023 and a Series C in 2021 at $740 million valuation. The new capital supports commercial scaling with employers and health plans such as Benjamin Moore, HCSC, Heritage Group, Invitation Homes, Bayview, and Medline. Twin Health's approach addresses the needs of nearly 50 million Americans with diabetes by focusing on prevention and personalized care, differentiating from symptom management. It helps clients manage rising demand for GLP-1 strategies and reduce costs, with investors highlighting its inflection point for broader adoption among large corporates and health plans. |
| Dec 2023 | Series D | Temasek (lead); ICONIQ Capital; Helena; Sofina; Peak XV Partners | $50M | - | Twin Health is a digital health company offering the Whole Body Digital Twin™ technology, an AI-powered platform that creates personalized metabolic models from wearable sensors, lab data, and user inputs to provide precise guidance on nutrition, sleep, activity, and stress for reversing chronic metabolic diseases like type 2 diabetes, prediabetes, and obesity. The service is delivered via an app with support from a licensed clinical care team, emphasizing medication-free approaches and performance-based pricing where clients pay only for achieved clinical outcomes such as A1C reduction, weight loss, or medication elimination. On December 13, 2023, Twin Health announced a $50 million Series D funding round led by Temasek Holdings, with participation from existing investors ICONIQ Growth, Peak XV Partners (formerly Sequoia India), Sofina, and Helena. The funds aim to expand the technology and clinical services to more U.S. members through health plans and employer partners, scaling coverage which already reached over 4 million lives at the time. CEO Jahangir Mohammed, co-founder with CTO Terry Poon, highlighted the strategy to achieve lower costs, better outcomes, and higher member satisfaction. Key traction includes the world's first randomized controlled trial (RCT) for digital twin-based reversal of chronic metabolic disease, with one-year results published in the American Association of Clinical Endocrinology showing a 2.9% HbA1c reduction (from 9.0% to 6.1%), 94% elimination of type 2 diabetes medications, 16.3 lbs average weight loss, and 64% normalization of non-alcoholic fatty liver disease in the intervention group. The RCT, now in its third year, demonstrates sustained outcomes, supporting Twin Health's mission amid rising global prevalence of metabolic syndrome affecting 20-25% worldwide and 415 million with type 2 diabetes. The company operates in a market where chronic metabolic diseases impact 60% of Americans, positioning its root-cause-focused, continuous care model against traditional episodic interventions reliant on medications. Board member Kevin Johnson, former Starbucks CEO, praised the approach for enabling health reversal and cost savings for households and employers. |
| Oct 2021 | Series C | ICONIQ Capital (lead); LTS Investments; Corner Ventures; Helena; Sofina; Perceptive Advisors; Peak XV Partners | $155M | $740M | Twin Health is a digital health company based in Mountain View, California, and Chennai, India, that develops the Whole Body Digital Twin, an AI-powered precision health platform using wearable sensors, lab testing, and patient data to model individual metabolism and manage chronic metabolic conditions like type 2 diabetes and obesity. The platform aims to provide personalized interventions to improve outcomes such as weight loss, glucose control, and reduced medication needs, as demonstrated in a randomized clinical trial published in Endocrine Practice. In October 2021, Twin Health raised $140 million in a Series C funding round led by ICONIQ Growth with participation from Sequoia Capital, Perceptive Advisors, Corner Ventures, LTS Investments, Helena, and Sofina, valuing the company at $740 million post-money. The funding supported US expansion amid growing interest in metabolic health following Teladoc's Livongo acquisition. Twin Health has continued raising capital in subsequent rounds, including a $50 million Series D in December 2023 from Temasek, Helena Capital Partners, ICONIQ Growth, Peak XV Partners, and Sofina, and earlier a $53 million Series E nearing $1 billion valuation. |
| Oct 2020 | Series B | Corner Ventures (lead); Sequoia Capital (lead) | $26M | - | Twin Health is a Mountain View, California-based company founded in 2018 that develops the Whole Body Digital Twin, an AI-powered precision health platform to reverse and prevent chronic metabolic diseases like diabetes through personalized guidance on nutrition, sleep, activity, and breathing. The platform connects patients with clinical care teams and partners with employers and health plans on a performance-based pricing model, charging only for achieved outcomes such as A1C reduction, weight loss, or medication elimination. Subsequent funding includes a Series C of $140-154.81 million in October 2021 or July 2021 led by ICONIQ Growth with participation from Sequoia Capital India, Perceptive Advisors, Corner Ventures, and others to scale operations in the US and India. Later rounds feature Series D of $51.58 million in November 2023 and Series E of $53 million (or $48.84 million) in May or August 2025 led by Maj Invest, reaching a post-money valuation of approximately $950 million, with total funding exceeding $300 million across rounds. Twin Health demonstrates strong traction with 90%+ client retention, under 1% voluntary churn, high conversion rates, and partnerships with entities like Cleveland Clinic, Benjamin Moore, HCSC, and Medline. A 2025 Cleveland Clinic trial published in NEJM Catalyst showed 71% of participants reduced A1C and often eliminated medications using the digital twin. The company positions itself against high-cost GLP-1 drugs, emphasizing scalable, medication-free metabolic care for employers and health plans amid rising diabetes and obesity challenges. |
| Jun 2020 | Series A | Sequoia Capital (lead) | $18M | $71M | Twin Health is a Mountain View, CA-based healthcare company founded in 2018 by Jahangir Mohammed, focused on reversing and preventing chronic metabolic diseases like diabetes and obesity through a 'digital twin' platform that integrates clinical care teams, health data monitoring tools, sensors, and AI with employers and health plans. The platform connects patients with personalized treatment using IoT devices and machine learning. The company raised an $8.03 million Series A-2 round on June 18, 2020, led by Sequoia Capital, at a post-money valuation of $70.84 million with a price per share of $1.40 and 5,725,078 shares outstanding. Twin Health's overall strategy involves expanding virtual care for metabolic conditions amid growing industry interest post-Teladoc's Livongo acquisition. Investors in early rounds included Sequoia Capital India and DAG Ventures. The company progressed to larger raises, including $25.5 million Series B in October 2020, $140 million Series C in 2021 at $740 million valuation led by ICONIQ and Sequoia, and Series E $53 million in 2025 nearing $1 billion valuation with partners like Temasek and Peak XV. |
Who has invested in Twin Health?
10 investors have backed Twin Health across its funding rounds, including ICONIQ Capital, Sequoia Capital, Peak XV Partners, Temasek, Sofina and Corner Ventures.
Lead investors include Maj Invest Equity, Temasek, ICONIQ Capital, Corner Ventures and Sequoia Capital.
Twin Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| San Francisco, CA | 3 | Lead | Oct 2021 | |
 Singapore | 2 | Lead | Dec 2023 | |
| San Francisco, CA | 2 | Lead | Jun 2020 | |
| San Francisco, CA | 2 | Lead | Oct 2020 | |
| Los Angeles, CA | 2 | Participant | Oct 2021 | |
 Brussels | 2 | Participant | Oct 2021 | |
 Bangalore | 2 | Participant | Oct 2021 | |
 São Paulo | 1 | Participant | Oct 2021 | |
This data is available for Pro users. Sign up to see all 10 Twin Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialTwin Health Competitors
Twin Health competitors include listed companies like Tempus AI and XtalPi, and private ones like Cult.fit, Welle, Evidation Health and Forward.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| United States | Publicly listed | $1.3B | ($131M) | $15B | 10.1x | |
| Bangalore | Private | $74M | - | $1.5B | - | |
| Los Angeles, CA | Private | - | - | $1.2B | - | |
| San Francisco, CA | Private | - | - | $1B | - | |
| San Francisco, CA | Private | - | - | $1B | - | |
 China | Publicly listed | $120M | $22M | $3.8B | 21.5x |
Twin Health Public Comps
Twin Health is still privately-owned, but its public comps include BigBear.ai, Fractal Analytics, Nutex Health, Indegene, Certara, JMDC, Shenzhen Ysstech Info, Omada Health, ZoomInfo and Braiin.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $128M | ($295M) | 8.3x | 7.6x | (3.6x) | (27.8x) | |||
| $344M | $50M | 3.7x | 3.4x | 25.8x | 21.0x | |||
| $875M | $288M | 2.0x | 2.0x | 6.0x | 6.4x | |||
| $366M | $68M | 3.7x | 3.3x | 19.9x | 18.2x | |||
| $419M | $103M | 3.4x | 3.6x | 13.9x | 12.0x | |||
| $324M | $88M | 5.0x | 4.6x | 18.4x | 17.9x | |||
| $205M | $4M | 7.2x | - | 378.8x | - | |||
| $260M | ($10M) | 3.8x | 3.1x | (98.6x) | 48.5x | |||
This data is available for Pro users. Sign up to see all Twin Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Twin Health
| When was Twin Health founded? | Twin Health was founded in 2018. |
| Where is Twin Health headquartered? | Twin Health is headquartered in San Francisco, CA, United States. |
| Is Twin Health publicly listed? | No, Twin Health is a private, VC-backed company. |
| What is Twin Health's valuation? | Twin Health was last valued at $1.4B in its undisclosed-stage round in September 2026. |
| How much funding has Twin Health raised? | Twin Health has raised $409M across 7 funding rounds. |
| What was Twin Health's last funding round? | Twin Health's last funding round was a $59M undisclosed-stage round in September 2026. |
| Who are Twin Health's investors? | Twin Health's investors include ICONIQ Capital, Temasek, Sequoia Capital, Corner Ventures, Helena, Sofina, Peak XV Partners, LTS Investments, Maj Invest Equity and Perceptive Advisors. |
| Which companies are comparable to Twin Health? | Companies comparable to Twin Health include Tempus AI, Cult.fit, Welle, Evidation Health, Forward and XtalPi. |
See companies similar to Twin Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.